Aviva’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.8M | Sell |
164,029
-1,916
| -1% | -$176K | 0.02% | 464 |
|
|
2025
Q4 | $14.9M | Buy |
165,945
+8,649
| +5% | +$820K | 0.03% | 464 |
|
|
2025
Q3 | $15.5M | Buy |
157,296
+9,485
| +6% | +$940K | 0.03% | 440 |
|
|
2025
Q2 | $13.5M | Buy |
147,811
+8,824
| +6% | +$853K | 0.03% | 458 |
|
|
2025
Q1 | $15.7M | Buy |
138,987
+16,213
| +13% | +$1.73M | 0.04% | 387 |
|
|
2024
Q4 | $13M | Buy |
122,774
+62,507
| +104% | +$6.71M | 0.03% | 396 |
|
|
2024
Q3 | $6.51M | Buy |
60,267
+843
| +1% | +$92K | 0.02% | 457 |
|
|
2024
Q2 | $6.45M | Sell |
59,424
-4,111
| -6% | -$485K | 0.02% | 480 |
|
|
2024
Q1 | $8.39M | Sell |
63,535
-59,721
| -48% | -$7.46M | 0.03% | 468 |
|
|
2023
Q4 | $15M | Buy |
123,256
+55,788
| +83% | +$6.23M | 0.05% | 383 |
|
|
2023
Q3 | $7.57M | Sell |
67,468
-95,122
| -59% | -$12.1M | 0.03% | 458 |
|
|
2023
Q2 | $23.7M | Sell |
162,590
-44,925
| -22% | -$6.11M | 0.1% | 259 |
|
|
2023
Q1 | $26.8M | Buy |
207,515
+179,057
| +629% | +$22.5M | 0.12% | 249 |
|
|
2022
Q4 | $3.63M | Sell |
28,458
-1,098
| -4% | -$127K | 0.02% | 625 |
|
|
2022
Q3 | $3.09M | Buy |
29,556
+43
| +0.1% | +$4.72K | 0.02% | 641 |
|
|
2022
Q2 | $3.1M | Sell |
29,513
-1,123
| -4% | -$133K | 0.02% | 680 |
|
|
2022
Q1 | $3.92M | Sell |
30,636
-778
| -2% | -$93.8K | 0.02% | 638 |
|
|
2021
Q4 | $3.88M | Sell |
31,414
-5,164
| -14% | -$676K | 0.02% | 645 |
|
|
2021
Q3 | $5.2M | Sell |
36,578
-32,540
| -47% | -$4.79M | 0.02% | 568 |
|
|
2021
Q2 | $10.8M | Sell |
69,118
-1,668
| -2% | -$270K | 0.05% | 370 |
|
|
2021
Q1 | $11M | Buy |
70,786
+507
| +0.7% | +$78.5K | 0.05% | 318 |
|
|
2020
Q4 | $10.5M | Buy |
70,279
+1,441
| +2% | +$204K | 0.05% | 316 |
|
|
2020
Q3 | $9.1M | Sell |
68,838
-2,127
| -3% | -$278K | 0.05% | 301 |
|
|
2020
Q2 | $8.22M | Buy |
70,965
+21,891
| +45% | +$2.52M | 0.05% | 320 |
|
|
2020
Q1 | $4.82M | Sell |
49,074
-1,291
| -3% | -$169K | 0.04% | 407 |
|
|
2019
Q4 | $7.32M | Sell |
50,365
-2,327
| -4% | -$321K | 0.04% | 356 |
|
|
2019
Q3 | $7.02M | Sell |
52,692
-24,805
| -32% | -$3.2M | 0.05% | 326 |
|
|
2019
Q2 | $8.86M | Sell |
77,497
-1,813
| -2% | -$212K | 0.06% | 300 |
|
|
2019
Q1 | $9.83M | Buy |
79,310
+774
| +1% | +$88K | 0.07% | 279 |
|
|
2018
Q4 | $7.91M | Sell |
78,536
-23,519
| -23% | -$2.64M | 0.06% | 306 |
|
|
2018
Q3 | $13M | Sell |
102,055
-3,076
| -3% | -$366K | 0.07% | 277 |
|
|
2018
Q2 | $11.4M | Sell |
105,131
-914
| -0.9% | -$99.5K | 0.07% | 284 |
|
|
2018
Q1 | $11.2M | Sell |
106,045
-8,864
| -8% | -$1.03M | 0.07% | 279 |
|
|
2017
Q4 | $13.5M | Sell |
114,909
-15,850
| -12% | -$1.79M | 0.08% | 274 |
|
|
2017
Q3 | $14.9M | Buy |
130,759
+1,741
| +1% | +$201K | 0.08% | 269 |
|
|
2017
Q2 | $16.1M | Buy |
129,018
+2,173
| +2% | +$258K | 0.09% | 250 |
|
|
2017
Q1 | $15M | Sell |
126,845
-7,387
| -6% | -$837K | 0.09% | 254 |
|
|
2016
Q4 | $13.5M | Buy |
134,232
+7,762
| +6% | +$832K | 0.08% | 266 |
|
|
2016
Q3 | $16M | Buy |
126,470
+3,797
| +3% | +$469K | 0.1% | 238 |
|
|
2016
Q2 | $14.3M | Buy |
122,673
+19,014
| +18% | +$2.15M | 0.1% | 243 |
|
|
2016
Q1 | $10.7M | Buy |
103,659
+12,836
| +14% | +$1.24M | 0.08% | 276 |
|
|
2015
Q4 | $9.05M | Sell |
90,823
-83
| -0.1% | -$8.12K | 0.07% | 308 |
|
|
2015
Q3 | $8.29M | Buy |
90,906
+1,145
| +1% | +$115K | 0.07% | 307 |
|
|
2015
Q2 | $9.52M | Sell |
89,761
-3,369
| -4% | -$373K | 0.07% | 313 |
|
|
2015
Q1 | $10.6M | Buy |
93,130
+22,187
| +31% | +$2.53M | 0.07% | 311 |
|
|
2014
Q4 | $7.81M | Sell |
70,943
-248
| -0.3% | -$26.1K | 0.06% | 361 |
|
|
2014
Q3 | $6.95M | Sell |
71,191
-133
| -0.2% | -$13.1K | 0.06% | 385 |
|
|
2014
Q2 | $7.19M | Sell |
71,324
-505
| -0.7% | -$49.3K | 0.06% | 387 |
|
|
2014
Q1 | $6.6M | Buy |
71,829
+3,316
| +5% | +$306K | 0.05% | 383 |
|
|
2013
Q4 | $6.2M | Buy |
68,513
+2,323
| +4% | +$201K | 0.05% | 384 |
|
|
2013
Q3 | $5.28M | Buy |
66,190
+11,837
| +22% | +$932K | 0.05% | 397 |
|
|
2013
Q2 | $3.96M | Buy |
+54,353
| New | +$4.06M | 0.04% | 413 |
|
Other funds holding ZBH
VCM
VPM
Aviva's ZBH Position: Q1 2026 in Review
Aviva reduced its Zimmer Biomet (ZBH) stake by 1.2% in Q1 2026, selling an estimated $176K and leaving 164,029 shares worth $14.8M. The position accounts for 0.02% of the portfolio, ranked #464.
Aviva first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.8M in Q1 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Aviva held 164,029 shares of Zimmer Biomet worth $14.8M as of Q1 2026.
- Aviva sold 1,916 Zimmer Biomet shares in Q1 2026, an estimated $176K.
- Zimmer Biomet made up 0.02% of Aviva's portfolio in Q1 2026, its #464 holding.
- Aviva first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Aviva's Zimmer Biomet position peaked at $26.8M in Q1 2023.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.